Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 799

SoftBank points OakNorth toward $440m

The digital bank is now valued at $2.8bn, following a $440m round led by a $390m investment by SoftBank Vision Fund and backed by Clermont Group.

Feb 8, 2019

Foot Locker kicks $100m into Goat Group

The retailer has invested $100m in footwear marketplace Goat Group, which already counts Matrix Partners, Upfront Ventures, Webb Investment Network and Accel as shareholders.

Feb 8, 2019

Corporates help scale Himalaya with $100m

Ximalaya FM and Susquehanna International Group have taken part in a $100m round to launch podcast network Himalaya, which was spun out of Ximalaya.

Feb 8, 2019

Waite makes her way to new Millennium

Rita Waite, a Juniper Ventures investment manager who was part of this year's GCV Rising Stars list, will join financial services firm Millennium's payment products team.

Feb 8, 2019

Spin Memory banks Abies for series B

NYU and Allied Minds-founded Ram technology developer Spin Memory has unveiled deep tech-focused VC firm Abies Ventures as an investor in a $52m series B first announced late last year.

Feb 8, 2019

Ligand Pharmaceuticals administers $3m to Dianomi

Dianomi Therapeutics will work with Ligand on a medication delivery platform based on research from University of Wisconsin-Madison initially targeting pain disorders and osteoarthritis.

Feb 8, 2019

Lime climbs to $310m series D

The electric scooter rental platform is now valued at $2.4bn, after securing $310m in a round co-led by GV that included its parent company, Alphabet.

Feb 7, 2019

DNAnexus raises $68m in latest funding sequence

GV and WuXi NextCode both returned to back a $68m round for DNANexus, bringing the biomedical informatics platform’s total funding to approximately $173m.

Feb 7, 2019

Calm meditates on $88m series B

The meditation app developer has quadrupled its valuation to $1bn in just eight months, in an $88m series B round featuring CAA.

Feb 7, 2019

Alector achieves $176m IPO

The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.

Feb 7, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here